IL33 and neoplasm: The discrepancies described in the papers on the role of IL-33/ST2 axis in intestinal tumorigenesis may be associated to variations in experimental design, models utilized (37, 39, 44, 45), use of chemotherapy in patients (44), as well as differences in their expression in the tumor epithelial cells, tumor microenvironment or tumor location (50).